Smart dosing could tame toxic TB drug side effects
Disease control
Not yet recruiting
This study aims to see if adjusting the dose of the antibiotic linezolid based on regular blood tests can reduce harmful side effects in people being treated for multidrug-resistant tuberculosis (MDR-TB). About 150 adults and teens in Guinea will receive the standard BPaL regimen…
Phase: PHASE4 • Sponsor: Marco Schiuma • Aim: Disease control
Last updated May 04, 2026 16:19 UTC